HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
We are delighted to have taken part in Shangai for the CPHI China ! 🇨🇳
This participation allowed us to meet the industry and connect with customers and partners from the Asian pharmaceutical supply chain, to discuss the heartening future of Hyaluronic Acid (HA) and another biopolymer, Polynucleotides.
Thanks to everyone who visited our booth and made this event a success.
Looking forward to the next edition !
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.